Unlocking Comparative Cardiology: A Definitive Collection on Precision Quantification, Advanced Imaging, and Revolutionary Interventions Across Species

Description: 

This essential five-source collection offers an in-depth, cross-species analysis of echocardiography, tackling challenges from normalizing heart size in animals spanning a "ten-thousandfold difference" (mouse to horse) to implementing cutting-edge transcatheter repairs. It synthesizes core techniques, comparative anatomy, and pioneering research, making it vital for anyone interested in advanced cardiac imaging.

Sessions include: (originally recorded during ASE 2025 Scientific Sessions). 

• Transesophageal Echocardiography in Pet Dogs Undergoing Mitral Valve TEER
• Human-Veterinary Challenge: Stump the Experts
• A Ten-Thousandfold Difference: Indexing the Left Ventricle from Mouse to Human to Horse
• Veterinary Abstract Showcase
• Comparative Aspects of Human and Veterinary Transthoracic Echocardiography

CME Information: 5.0 AMA PRA Category 1 Credit^TM 

CME Expiration: September 29, 2028.  CME Credits must be claimed by this date.

*NEW* - AAVSB RACE CE Information: This program has been RACE approved for 4 hours of continuing education credit in jurisdictions that recognize RACE approval. 

AAVSB RACE CE Expiration: October 20th, 2027. RACE CE Credits must be claimed by this date

Learning Objectives:

• Analyze the methods for indexing cardiac dimensions across diverse mammalian species
• Compare and contrast fundamental anatomical and technical differences between human and veterinary transthoracic echocardiography. 
• Evaluate the utility of advanced imaging and quantification techniques employed to improve diagnostic accuracy and reproducibility in veterinary patients
• Describe the procedural requirements and anatomical criteria for Transcatheter Edge-to-Edge Repair (TEER) in dogs with Myxomatous Mitral Valve Disease (MMVD)

Accreditation Statement & CME Information (Pending Approval)

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, the American Board of Pediatrics (ABP) MOC program, and/or the American Board of Anesthesiology’s (ABA) Maintenance of Certification in Anesthesiology Program® or MOCA 2.0®. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points and/or ABA MOCA 2.0®.   Physicians will earn MOC and/or MOCA 2.0 points equivalent to the amount of CME credits claimed for the activity.

ARDMS and CCI recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.

Disclosures:

ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following faculty members have no relevant financial relationships with ineligible companies:

• Saki Kadotani, DVM
• Brianna Potter, DVM, MS
• Christopher Orton, DVM, MS, PhD
• Ryan Fries, DVM, DACVIM
• Rebecca Stepien, DVM, MS, DACVIM
• Piers Barker, MD, FASE
• Ashley Saunders, DVM
• Justin Allen, DVM, DACVIM
• Elizabeth McIlwain, MHS, ACS, RCS, FASE
• Jonathan Lindner, MD, FASE
• Judy Hung, MD, FASE
• Lynne O’Sullivan, DVM
• Vincent Sorrell, MD, FASE
• Virginia Luis Fuentes, MB, PhD
• John Bonagura, DVM, FASE, DACVIM
• Bruce Keene, DVM

All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:

• Rebecca Hahn, MD, FASE, FACC, FESC; Abbott Vascular, Bostin Scientific, Edwards Lifescience, Medtronic, Philips Healthcare (Speaker/Speakers Bureau)

Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies.  Click here for a list of these members.

None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies.  Click here for a list of ASE staff members.

No commercial support was provided for this activity.

• Contact:
  ASE Learning Hub